Don’t miss the latest developments in business and finance.

Hikal announces successful USFDA insepction of its API and Intermediates manufacturing facility

Image
Capital Market
Last Updated : Jan 11 2017 | 12:02 AM IST

At Jigani, Bangalore

Hikal announced that the Company's API and Intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the US FDA in compliance with their requirements. At the end of the successful inspection, the Company have been informed by the Investigator that zero 483 observations were issued. This was a routine inspection by the US FDA.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jan 10 2017 | 4:12 PM IST

Next Story